Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 6
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #228: Inside the Lilly-Atai Deal; An Update on the GH-AtaiBeckley Patent Standoff; Field Reacts to FDA’s Guidance; Resilient Readies Resubmission
Q3’26 Psychedelic Drug Development Pipeline: Bullseye Charts
The Vital Conference: Breckenridge 2026
JOURNEYS: A Film Experience + Live Conversation with the Filmmakers
Psychedelic Policy Briefing: Week of July 20th, 2026
Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten...
Pα+ Psychedelic Bulletin #224: Reactions to Trump’s Psychedelics Executive Order, and...
God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive...
The Optimisation Problem: What Bryan Johnson’s 5-MeO-DMT Experiment Reveals About Psychedelics...
Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium
Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona
Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...
Why Ketamine Is Changing Psychiatry
Trump’s Psychedelics Executive Order: Reactions From Across the Field and Beyond
Whitehouse Directs FDA, HHS and VA to Expand Psychedelic Research Pathways
Load more